This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Biohaven Therapeutics Ltd.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Melissa Beiner - Innovator in Neuralgia Treatment
Introduction
Melissa Beiner is an accomplished inventor based in New Haven, CT (US). She is currently associated with Biohaven Therapeutics Ltd. Her work focuses on innovative methods for treating neuralgia, particularly trigeminal neuralgia, through the use of CGRP receptor antagonists.
Latest Patent Applications
Melissa Beiner has filed a patent application titled "CGRP Antagonists for Treating Trigeminal Neuralgia." This application provides methods for treating neuralgia, including trigeminal neuralgia, using one or more CGRP receptor antagonists and/or pharmaceutical compositions. The methods aim to treat, alleviate, and reduce the risk of neuralgia in mammalian subjects, including humans. The application highlights the utility of CGRP receptor antagonists as described in various formulas.
Conclusion
Melissa Beiner's contributions to the field of neuralgia treatment through her innovative patent application demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact the lives of those suffering from trigeminal neuralgia.